JENNIFER LEVINE: Open Payments
NPI 1013935790 · NEPTUNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$439 in 14 payments from 6 companies in 2025. Trend: 2023 $740 · 2024 $838 · 2025 $439
Food & beverage: $330Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $263 |
| Janssen Pharmaceuticals, Inc | 4 | $64 |
| E.R. Squibb & Sons, L.L.C. | 3 | $50 |
| Lilly USA, LLC | 1 | $24 |
| ABBVIE INC. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
Products named: UZEDY, COBENFY, INVEGA SUSTENNA, AUSTEDO XR, AMYVID, SPRAVATO, VRAYLAR, CAPLYTA.
Industry payments across NJ — which companies pay providers there.
